RAPS: FDA Finalizes Expedited Product Guidance With Hundreds of Major, Minor Changes
05.06.2014
The US Food and Drug Administration (FDA) has finalized its long sought-after guidance document on the use of its four expedited drug approval programs, including the recently instituted breakthrough product designation.
SciencePharma
